Table S4.
General demographics and histopathology of patients with pancreatic cancer by HGF status
| Pancreatic cancer with detectable HGF, n = 23 | Pancreatic cancer with undetectable HGF, n = 198 | P value | |
| Age, y, mean ± SD | 68.1 ± 9.4 | 66.8 ± 10.6 | 0.579 |
| Gender, n (%) | 0.251 | ||
| Male | 10 (8.3) | 111 (91.7) | |
| Female | 13 (13.0) | 87 (87.0) | |
| Race, n (%) | 0.011 | ||
| White | 16 (8.5) | 172 (91.5) | |
| African-American | — | 4 (100.0) | |
| Hispanic | 1 (100.0) | — | |
| Asian | 3 (25.0) | 9 (75.0) | |
| Other or unknown | 3 (18.7) | 13 (81.3) | |
| Classic symptoms of PDAC, n (%) | 0.044 | ||
| Absent | 1 (2.2) | 44 (97.8) | |
| Present | 22 (12.5) | 154 (87.5) | |
| Abdominal pain, n (%) | 0.588 | ||
| Absent | 12 (9.5) | 115 (90.5) | |
| Present | 11 (11.7) | 83 (88.3) | |
| Jaundice, n (%) | 0.524 | ||
| Absent | 10 (9.1) | 100 (90.9) | |
| Present | 13 (11.7) | 98 (88.3) | |
| Tumor size, cm, median (IQR) | 2.7 (2.0–4.0) | 3.0 (2.4–3.8) | 0.619 |
| Tumor size, n (%) | 0.648 | ||
| ≤ 1.00 cm | — | 2 (100.0) | |
| 1.01–1.50 cm | 5 (22.7) | 17 (77.3) | |
| 1.51–2.00 cm | 1 (8.3) | 11 (91.7) | |
| 2.01–2.50 cm | 4 (8.5) | 43 (91.5) | |
| 2.51–3.00 cm | 4 (10.5) | 34 (89.5) | |
| 3.01–3.50 cm | 2 (5.6) | 34 (94.4) | |
| 3.51–4.00 cm | 2 (9.1) | 20 (90.9) | |
| >4.01 cm | 5 (11.9) | 37 (88.1) | |
| AJCC T stage, n (%) | 0.822 | ||
| T1 | 3 (13.6) | 19 (86.4) | |
| T2 | 4 (8.7) | 42 (91.3) | |
| T3 | 16 (10.5) | 137 (89.5) | |
| AJCC N stage, n (%) | 0.717 | ||
| N0 | 6 (11.8) | 45 (88.2) | |
| N1 | 17 (10.0) | 153 (90.0) | |
| AJCC M stage, n (%) | — | ||
| M0 | 23 (10.4) | 198 (89.6) | |
| M1 | — | ||
| AJCC stage, n (%) | 0.364 | ||
| IA | 3 (25.0) | 9 (75.0) | |
| IB | 1 (5.9) | 16 (94.1) | |
| IIA | 2 (9.1) | 20 (90.9) | |
| IIB | 17 (10.0) | 153 (90.0) | |
| Grade of tumor differentiation, n (%) | 0.757 | ||
| Well/moderately differentiated | 14 (9.9) | 127 (90.1) | |
| Poorly differentiated | 9 (11.3) | 71 (88.7) | |
| Perineural invasion, n (%) | 0.841 | ||
| Absent | 3 (11.5) | 23 (88.5) | |
| Present | 20 (10.3) | 175 (89.7) | |
| Lymphovascular invasion, n (%) | 0.967 | ||
| Absent | 8 (10.5) | 68 (89.5) | |
| Present | 15 (10.3) | 130 (89.7) | |
| Number of harvested nodes, median (IQR) | 20 (17–28) | 19 (15–27) | 0.173 |
| Number of harvested nodes, n (%) | 0.261 | ||
| ≤20 nodes | 9 (8.1) | 102 (91.9) | |
| >20 nodes | 14 (12.7) | 96 (87.3) | |
| Number of positive nodes, median (IQR) | 2 (0–5) | 2 (1–5) | 0.965 |
| Positive nodes, n (%) | 0.717 | ||
| Absent | 6 (11.8) | 45 (88.2) | |
| Present | 17 (10.0) | 153 (90.0) |